Loading...
Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization
[Image: see text] Lenvatinib is an oral multikinase inhibitor that selectively inhibits vascular endothelial growth factor (VEGF) receptors 1 to 3 and other proangiogenic and oncogenic pathway-related receptor tyrosine kinases. To elucidate the origin of the potency of lenvatinib in VEGF receptor 2...
Na minha lista:
| Udgivet i: | ACS Med Chem Lett |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Chemical
Society
2014
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4291723/ https://ncbi.nlm.nih.gov/pubmed/25589937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml500394m |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|